[Intratympanic dexamethasone injections for intractable sudden sensorineural hearing loss].

Abstract

OBJECTIVE To investigate the efficacy of intratympanic dexamethasone injection (IDI) for 23 patients with intractable sudden sensorineural hearing loss (SSNHL). METHOD Dexamethasone (5 g/ml) was injected into the middle ear. The injection was repeated once two days and had a total of 4 doses (10 mg). RESULT The 23 patients were followed up for one month. Eight of 23 patients (34.8%) demonstrated a 17 to approximately 54 dB improvement in PTA and 15 of 23 (65.2%) had no response. CONCLUSION IDI is a simple and effective treatment for SSNHL patient who had not responded to conventional therapy, although hearing was rarely improved to normal levels.

Cite this paper

@article{Ren2006IntratympanicDI, title={[Intratympanic dexamethasone injections for intractable sudden sensorineural hearing loss].}, author={Jihao Ren and Yongde Lu and Tuanfang Yin and Bin Liu and Yilin Ge}, journal={Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology}, year={2006}, volume={20 5}, pages={219-21} }